Seer Q2 2026 revenue down 23% to $3.1M; net loss $16.9M; reaffirms FY26 guidance

Seer, Inc.

Revenue $3.1M vs $4.1M in Q2 2025, a 23% decline on macro headwinds and longer sales cycles.
Net loss narrowed to $16.9M from $19.4M; operating expenses fell 19% to $18.3M.
Cash, equivalents and investments ~$209.5M at June 30, 2026; repurchased ~200,000 shares.
Reaffirms FY2026 revenue guidance of $16M-$18M, implying ~3% growth at midpoint.
Initiated ITC investigation against Nanomics for alleged patent infringement on Proteograph.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.